Skip to Content

Fluocinonide Topical Dosage

Applies to the following strength(s): 0.05% ; 0.1%

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Dermatitis

0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Adult Dose for Eczema

0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Adult Dose for Atopic Dermatitis

0.1% cream: Apply a thin layer to affected area once a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of atopic dermatitis

Usual Adult Dose for Psoriasis

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of psoriasis

Usual Pediatric Dose for Dermatitis

12 years or older:
0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Pediatric Dose for Eczema

12 years or older:
0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Pediatric Dose for Psoriasis

12 years or older:
0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of psoriasis

Usual Pediatric Dose for Atopic Dermatitis

12 years or older:
0.1% cream: Apply a thin layer to affected area once a day

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of atopic dermatitis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-This drug should not be used on the face, groin, or axillae.
-The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
-Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Storage requirements:
-Excessive heat should be avoided.

General:
-This drug should not be used in the treatment of rosacea or perioral dermatitis.

Monitoring:
-Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
-Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.

Hide